• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

PE Firm Frazier Healthcare Partners Closes $1.4B Growth Buyout Fund

by Fred Pennic 05/27/2021 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
PE Firm Frazier Healthcare Partners Closes $1.4B Growth Buyout Fund

What You Should Know:

–  Frazier Healthcare Partners, a Seattle-based healthcare private equity firm announced the close of its tenth global buyouts fund and 13th fund across buyouts and life sciences. Investment focus will continue to be middle market provider-based businesses, with virtual health as a major component. The oversubscribed $1.4 billion fund, FHGB X, is significantly larger than FHGB IX, which closed at $780M in 2018.

– Frazier, 30 years strong this year, received global support from new and existing limited partners, which represent some of the most prestigious public pension funds, financial institutions, foundations and endowments, family offices, corporate pensions and sovereign wealth funds. The majority of investors from FHGB IX increased their commitment for FHGB X.

– Founded in 1991, Frazier Healthcare Partners, with the addition of FHGB X, has more than $6.2 billion total capital raised.

Thesis-Driven, Executive in Residence-Centric Investment Model

Frazier focuses on acquiring controlling interests in profitable, lower middle-market healthcare companies with EBITDA between $10 million and $75 million where it can invest between $50M and $300M of equity. Investments can take the form of corporate carveouts of private and publicly traded companies, recapitalizations and buy-and-build strategies.

Leveraging its extensive network and human capital team, Frazier pairs proven executives with curated investment theses. This enables the pursuit of unique investment opportunities with the EIR assuming an Executive Chairman or CEO role.

“Our thesis-driven, executive in residence-centered strategy has enabled the Frazier franchise to become a preferred partner to both serially successful executives and sellers of companies in targeted sectors of interest,” said Ben Magnano, co-managing partner at Frazier. “Our three decades of focusing on the healthcare industry, breadth and depth of our ecosystem and team resonated with both new and existing investors.”

Recent Investments & Exits

Recent investments include the corporate carveout of MedData from Mednax (Ticker: MD) in October 2019. MedData is a leading provider of technology-enabled revenue cycle management services for hospitals, health systems and healthcare providers. More recently, in December 2020, Frazier acquired a 50% stake in CSafe Global, a Dayton, Ohio-based provider of cold chain shipping and air cargo solutions to the life science and pharmaceutical industries.

Recent exits include the December 2020 sale of PCI, a leading pharmaceutical and biopharmaceutical global supply-chain solutions provider, to Kohlberg and Mubadala in a $3.0+ billion transaction. Northfield, a provider of operating room instrument, scope and power system repair services was sold to Agiliti in March 2021 for $475 million.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Partners, Private Equity

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |